Open access peer-reviewed chapter

The Role of Natural Antioxidants in Cancer Disease

Written By

Carmen Valadez-Vega, Luis Delgado-Olivares, José A. Morales González, Ernesto Alanís García, José Roberto Villagomez Ibarra, Esther Ramírez Moreno , Manuel Sánchez Gutiérrez, María Teresa Sumaya Martínez, Zuñiga Pérez Clara and Zuli Calderón Ramos

Submitted: March 30th, 2012 Reviewed: July 11th, 2012 Published: May 22nd, 2013

DOI: 10.5772/51503

Chapter metrics overview

3,564 Chapter Downloads

View Full Metrics

1. Introduction

Cell oxidation can lead to the onset and development of a wide range of diseases including Alzheimer and Parkinson, the pathologies caused by diabetes, rheumatoid arthritis, neurodegeneration in motor neuron diseases, and cancer. Reactive species (RS) of various types are powerful oxidizing agents, capable of damaging DNA and other biomolecules. Increased formation of RS can promote the development of malignancy, ‘normal’ rates of RS generation may account for the increased risk of cancer development.

Oxidants and free radicals are inevitably produced during the majority of physiological and metabolic processes and the human body has defensive antioxidant mechanisms; these mechanisms vary according to cell and tissue type and may act antagonistically or synergistically. They include natural enzymes like Superoxide dismutase (SOD), Catalase (CAT), and Glutathione peroxidase (GPx), as well as antioxidants such as vitamins, carotenoids, polyphenols, and other natural antioxidants, which have attracted great interest in recent years.

There has been a great deal of interest of late in the role of complementary and alternative drugs for the treatment of various acute and chronic diseases. Among the several classes of phytochemicals, interest has focused on the anti-inflammatory and antioxidant properties of the polyphenols that are found in various botanical agents. Plant vegetables and spices used in folk and traditional medicine have gained wide acceptance as one of the main sources of prophylactic and chemopreventive drug discoveries and development.

Recently, researches on medicinal plants has drawn global attention; large bodies of evidence have accumulated to demonstrate the promising potential of medicinal plants used in various traditional, complementary, and alternate treatment systems of human diseases. The plants are rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, flavonoids, etc., which have been screened in vivoand in vitroand have indicated antioxidant and anticarcinogenic properties and which are used to developed drugs or dietary supplements.

Evidence suggests that the plant kingdom is considered a good candidate for chemoprevention and cancer therapy due to the high concentration and wide variety of antioxidants such as resveratrol, genestein, beicalein, vitamin A, vitamin C, polyphenols, (‒)‒Epigallocatechin 3-gallate, flavonoids, polyphenols, gallic acid, glycosides, verbascoside, calceorioside, epicatechin, quercetin, curcumin, lovastatin, and many other types of compounds with the capability to inhibit the cell proliferation of different cancer cells in vitroand in vitro, such as colon cancer (HT-29, SW48, HCT116), breast (MCF7, MDA), cervix (HeLa, SiHa, Ca-Ski, C33-A), liver (Hep G2), skin (A 431), fibroblasts (3T3 SV40), and many other malignant cells; studies have indicated that antioxidants can be employed efficiently as chemopreventives and as effective inhibitors of cell proliferation, promoting cell apoptosis, and increasing detoxification enzymes, and inhibiting gene expression and scavenger Reactive oxygen species (ROS). Thus, many researchers are working with different types of natural antioxidants with the aim of finding those with the greatest capacity to inhibit the development of cancer both in vitroas well as in vivo, because these compounds have exhibited high potential for use not only in the treatment of this disease, but they also act as good chemoprotective agents.

Advertisement

2. Antioxidants

The production of ROS during metabolism is an inevitable phenomenon associated with the process of aerobic metabolism; on the other hand, we are exposed at all times to several exogenous sources of oxidant molecules, for example, environmental and pollutant factors and many dietary compounds, which increase their levels. ROS participate in different cellular processes; their intracellular levels are relatively low. However, because ROS are highly toxic when their concentration increases, the phenomenon denominated Oxidative stress (OS) is produced [123], which can injure various cellular biomolecules, causing serious damage to tissues and organs and resulting in chronic diseases [24]. Oxidative damage can be prevented by antioxidants, which are present within the cell at low concentrations compared with oxidant molecules [141, 50].

Antioxidants are capable of donating electrons to stabilize ROS and to inhibit their detrimental effects, including both endogenous (synthesized by the body itself) and exogenous molecules (those from external sources to the body) [141]. Endogenous antioxidants include Superoxide dismutase (SOD), which catalyzes the dismutation reaction of superoxide (O2•) into hydrogen peroxide (H2O2), which is in turn transformed into oxygen and water for the Catalase (CT), and in addition Glutathione peroxidase (GPx) can catalyze its reduction; however, if in the presence of transition metals such as iron, H2O2, by means of the Fenton reaction, can produce the hydroxyl radical (OH•); wich is of more reactive the ROS, capable to produce the majority of oxidative damage [24]. On the other hand, exogenous antioxidants can be from animal and plant sources; however, those of plant origin are of great interest because they can contain major antioxidant activity [19]. Different reports show that persons with a high intake of a diet rich in fruit and vegetables have an important risk reduction of developing cancer, mainly due to their antioxidant content [70]. Among the vegetable antioxidants are vitamins E and C, and ß-carotene, which are associated with diminished cardiovascular disease and a decreased risk of any cancer [48]. In particular, ß-carotene and vitamin E can reduce the risk of breast cancer, vitamin C, ß-carotene, and lutein/zeaxanthin possess a protector effect against ovarian cancer, and vitamin C, ß-carotene, and rivoflavin prevent colorectal cancer [70], while flavonoids such as plant phenolics and wine phenolics can inhibit lipid peroxidation and lipoxygenase enzymes. In addition, any microelement, such as Se, Zn, Mn, and Cu, can exhibit antioxidant activity [48, 24].

In recent years, interest has grown in the use of natural antioxidants for the prevention or treatment of different diseases related with OS; however despite the widespread information of the beneficial effects of antioxidants in the prevention of cancer, their use remains questionable, because different reports have shown that reducing the levels of ROS may have counterproductive effects because due to raising the risk of cancer; the latter may be due to that ROS can produce apoptosis in malignant cells [38, 101].

Advertisement

3. Molecular Studies of Natural Antioxidants

Different types of natural antioxidants are present in fruit and vegetables; they have synergistic interactions that are important due to their activity and regenerative potential. For example, ascorbate can regenerate into α-tocopherol [53], and the ascorbate radical is regenerated into other antioxidants via the thiol redox cycle. Taken together, all of these interactions are known as the “antioxidant network”.

Vitamin E is an antioxidant that penetrates rapidly through the skin and is incorporated into the cellular membranes, inhibiting lipid peroxidation; specifically, α-tocotrienol, the vitamin E isoform, demonstrates greatest protection. Additionally, vitamin E possesses antiproliferative properties that interfere in signal transduction and in inducing cell cycle arrest.

Tumor necrosis factor-alpha (TNF-α) is a cytokine that, under normal conditions, induces inflammation, tumor inhibition, and apoptotic cell death. However, when the former undergoes deregulation, it acts as a breast tumor promoter, enhancing the proliferation of chemically induced mammary tumors [113]. Phenolic antioxidants can block the increase of TNF-α at the transcriptional level in the nucleus, which suggests the molecular mechanism of phenolic antioxidants through control of cytokine induction [81].

Advertisement

4. Oxidative Stress and Diseases

The ROS, as the superoxide anion (O2), hydrogen peroxide (H2O2), and the hydroxyl radical (OH•), are produced during cell metabolism in the lysosomes, peroxisomes, endoplasmic reticulum in the process carried out to obtain energy such as Adenosine triphosphate (ATP) [108]. There are other sources of oxidant molecules, such as pollution, the environment, and certain foods. During recent years, it has been discovered that during aging, the mitochondria increase the levels of ROS production and antioxidant endogens are diminished [98, 13]. ROS play an important role in the physiological process; however, due to their toxicity, their levels must be controlled by the endogenous antioxidant system. But when ROS formation is increased, an imbalance is promoted between these and the antioxidant molecules; phenomenon known as Oxidative stress (OS) [123]. OS can cause oxidative damage of proteins, lipids, and nucleic acids, macromolecules involved in the cell function, membrane integrity, or in maintaining genetic information (nucleic acids) [44, 45, 65].

Proteins are responsible for different cell processes (enzymatic, hormonal, structural support). The oxidation of proteins produces disulfide crosslinks, nitration, or tyrosine residues, and carbonylation, resulting in the loss of the structure and function of proteins and fragmentation [11, 97]. But because the chaperones are susceptible to oxidative damage, allowing the accumulation of misfolding proteins and increasing their susceptibility to protease degradation [115], however, the proteasome also undergoes oxidation and its activity is diminished, which makes the aggregates accumulate in the cell wich have been associated with aging and various pathologies, such as cancer and neurodegenerative disorders, such as Parkinson, Huntington, and Alzheimer disease [98].

The brain is the organ with the highest oxygen consumption; it has high levels of fatty acids, iron, and low antioxidant defenses. This is an organ with major susceptibility to oxidative damage [141], producing neurodegeneration that results in different diseases such as Parkinson disease, Alzheimer disease, Down syndrome, autism, bipolar disorder, and epilepsy [23, 24], and the cognitive alteration known as Mild cognitive impairment (MCI), which is produced preferentially in regions of the brain involved in regulating cognition, contributing to the development of dementia [65]. Similar processes occur during aging, resulting in the genetic response of increasing levels of antioxidant enzymes and chaperone proteins [73]. Reduction of OS causes improvement of the long-term memory [102].

Polyunsaturated fatty acids (mainly compounds of the membranes) are susceptible to peroxidation, which affects the integrity of the membranes of organelles of the cell membrane and the respiratory chain, in turn affecting cell viability. Lipid peroxidation produces aldehydes such as 4-hydroxy-2 E-nonenal, which is toxic and is involved in alterations in Alzheimer disease and DNA damage, causing mutations associated with the development of cancer [38, 20].

Ribosomal RNA and transfer RNA constitute the majority of stable species of cellular RNA, which possess a greater oxidation rate than DNA. The major modification for oxidation into RNA comprises 8-hydroxyGuanine (8-oxoG), which under normal conditions is present three times more in non-ribosomal that in ribosomal RNA; however, when the cell is exposed to H2O2, the concentration of 8-oxoG in ribosomal RNA increases at the same levels in both RNA [97]. RNA oxidation can diminish the capacity of replacement oxidation of proteins [65, 44] and the inhibition of protein synthesis, cell cycle arrest, and cell death. Oxidation of RNA is involved in the development of cancer, viral infections, AIDS, hepatitis (VIH-1; HCV; 107, 148], and neurological diseases. It has been reported that each neurological disease, present a damage oxidative of RNA in a specific region on the brain, for example in Alzheimer disease, there are increased RNA oxidation in the hippocampus and cerebral neocortex, while in Parkinson disease, RNA oxidation is localized in the sustancia nigra[97].

On the other hand, high-fat diets induce obesity and insulin resistance, resulting in increased ROS production, which modifies sympathetic brain activity, which in turn contributes to the rise in blood pressure, increase in insulin resistance, and obesity [6]. Obesity is the principal factor in the development of the metabolic syndrome, due to that persons with obesity have deficient antioxidant defense and increased production of ROS [126, 30, 75], which leads to spoilage and subsequently cell death, resulting in tissue and organ damage, to tissues causing serious health problems such as insulin resistance [7], diabetes mellitus, and hypertension [82]. Moreover, in the metabolic syndrome, NAD(P)H oxidase, the major source of ROS in several tissues, is up-regulated, resulting in an increase of ROS production and the down-regulation of several antioxidant enzymes (SOD isoforms, GPx, and heme oxygenase) [114]. This enzyme, specifically in the type 4 isoform (NOX4), is implicated in the damage due to OS during cerebral ischemia [67].

The scientific literature has shown that oxidative stress is involved in the development of a wide range of disease, such as heart diseases, Hutchinson-Gilford syndrome or progeria, hypertensive brain injury, muscular dystrophy, multiple sclerosis, congenital cataract, retinal degeneration, retinopathy of the premature, autoimmune diseases, cardiovascular abnormalities, nephrological disorders, emphysema, stroke, rheumatoid arthritis, anemia, hepatitis, pancreatitis, aging, premature wrinkles and dry skin, endothelial dysfunction, and dermatitis, among others [83, 7, 137, 91, 23, ¸102].

However the most important damage caused by OS are the DNA modifications, which can result in permanent mutations, due to that oxidative damage also affects the proteins involved in repairing the harm or reducing the OS (the endogenous antioxidant); thus, oxidative damage to DNA can be the cause of the development of various diseases, such as cancer [13, 51].

Advertisement

5. Cancer

Cancer is unnatural cell growth, in which cells can lose their natural function and spread throughout the blood in the entire body. Breast cancer is the most commonly diagnosed cancer in industrialized countries and has the highest death toll [88]. OS is involved in the process of the development of cancer and tumors, due to that ROS can damage the macromolecules as lipids, which react with metals (such as free iron and copper) and produce aldehydes and synthesize malondialdehyde-inducing mutations [96] or cause breaks in the double chain, produce modifications in guanine and thymine bases, and sister chromatid exchanges [16], which can affect the activities of signal transduction, transcription factors, and gene tumor suppressors such as p53, which is a gene important in apoptosis and in cell cycle control. This inactivation can increase the expression of proto-oncogenes [96] which can produce major damage. Oxidative damage or genetic defects that result in some defective enzymes are incapable of repairing the mutations increase the incidence of age-dependent cancer [51].

On the other hand, treatments with anticancer drugs and radiation increase ROS and decrease antioxidants content, producing a state of severe oxidative stress and causing apoptosis, resulting in side effects [96], while persistent oxidative stress at sublethal levels can result in resistance to apoptosis [16].

Some microorganisms, as bacteria and viruses, are involved, via OS, in the process of the production of certain cancers such as, for example Helicobacter pylori, inducing gastric cancer and colon cancer through the production of SO• [96]. It has been proposed that lower antioxidant activity increases the risk of developing cancer; thus, ingestion of antioxidants can prevent cancerogenesis. However is not clear the decrease of antioxidants levels is not clear, in as much as in freshly cancerous tissue, MnSOD levels are elevated; therefore, some investigators have proposed that this antioxidant enzyme is involved in tumor invasion; thus, it is possible that antioxidants have a role as pro-oxidants. Another point to consider is that when the 8-oxodG level in DNA increases, cancer rates do not increase [96, 51]. However, OS is a factor for cancer and other diseases, but not the sole factor for diseases, because others, such as genetic factors (genetic predisposition) are involved.

Advertisement

6. Antioxidants and Cancer

Humans are constantly bombarded by exogenous factors such as Ultraviolet (UV) rays, tobacco smoke, and many others agents that cause OS. Such stress can also arise from the drugs that are employed in medical practice. On the other hand, under physiological conditions, normal aerobic metabolism gives rise to active and potentially dangerous oxidants in cells and tissues; these endogenous sources of OS include those derived from the activities of mitochondria or microsomes and peroxisomes in the electron transfer system and from the activities of the NADPH enzyme present in macrophages and neutrophils as a mechanism of protection against infection. Various reducing substances in the human body control the status of oxidation-reduction (redox), and a continuing imbalance in favor of oxidation causes several problems when it exceeds the capacity of such a control [96].

Otto Warburg was the first scientist to implicate oxygen in cancer [147] as far back as the 1920s. However, the underlying mechanism by which oxygen might contribute to the carcinogenic process was undetermined for many years. The discovery of superoxide dismutase in 1968 by [90] led to an explosion of research on the role of reactive oxygen in the pathologies of biological organisms. Reactive oxygen has been specifically connected with not only cancer, but also many other human diseases [5, 57]. For many years, research on OS focused primarily on determining how ROS damage cells through indiscriminate reactions with the macromolecular machinery of a cell, particularly lipids, proteins, and DNA. It is well known and in great detail the manner in which ROS react with lipids, leading to the peroxidation of biological membranes and resulting in necrotic lesions [43] and the way ROS react with the nucleotides of DNA, leading to potential mutations [17, 43, 139].

When produced in excess, ROS (some of which are free radicals) can seriously alter the structure of biological substrates such as proteins, lipids, lipoproteins, and Deoxyribonucleic acid (DNA). They possess a huge range of potential actions on cells, and one could easily envisage them as anti-cancer (e.g., by promoting cell-cycle stasis, senescence, apoptosis, necrosis or other types of cell death, and inhibiting angiogenesis), or as pro-cancer (promoting proliferation, invasiveness, angiogenesis, metastasis, and suppressing apoptosis).

Active oxygen may be involved in carcinogenesis through two possible mechanisms: induction of gene mutations that result from cell injury [34], and the effects on signal transduction and transcription factors. Which mechanism it follows depends on factors such as the type of active oxygen species involved and the intensity of stress [86]. Cellular targets affected by oxidative stress include DNA, phospholipids, proteins, and carbohydrates on the cell membrane. Oxidized and injured DNA has the potential to induce genetic mutation. That some telomere genes are highly susceptible to mutation in the presence of free radicals is now apparent, and it is known that tumor suppressor genes such as p53and cell cycle-related genes may undergo DNA damage. In addition, oxidized lipids react with metals to produce active substances (e.g., epoxides and aldehydes) or synthesize malondialdehyde, which has the potential to induce mutation. Active oxygen species act directly or indirectly via DNA damage on gene expression (DNA binding of transcription factors) and signaling at the cellular level.

Markers for OS can be divided into three categories:

  1. formation of modified molecules by free radical reactions;

  2. consumption or induction of antioxidant molecules or enzymes, and

  3. activation or inhibition of transcription factors.

Targets of free radicals include all types of molecules in the body. Among these, lipids, nucleic acids, and proteins are the major targets. Because free radicals are usually generated near membranes (cytoplasmic membrane, mitochondria, or endoplasmic reticulum), lipid peroxidation is the first reaction to occur. Lipid peroxidation products can be detected as classical Thiobarbituric acid (TBA)-reactive substances. Recently, the detection of 4-Hydroxy-2-nonenal (HNE) or Malondialdehyde (MDA) is favored due to their high specificity [32], aldehydes are end-products of lipid peroxidation but continue to be reactive with cell proteins [136].

Exposure to free radicals from a variety of sources has led organisms to develop a series of defense mechanisms that involve the following:

  1. preventative mechanisms;

  2. repair mechanisms;

  3. physical defenses, and

  4. antioxidant defenses.

Enzymatic antioxidant defenses include Superoxide dismutase (SOD), Glutathione peroxidase (GPx), and Catalase (CAT). Non-enzymatic antioxidants are represented by ascorbic acid (vitamin C), α-tocopherol (vitamin E), Glutathione (GSH), carotenoids, flavonoids, tannins, triterpepenoids, saponins, glycosides, steroids, and other antioxidants [46]. Under normal conditions, there is a balance between both the activities and the intracellular levels of these antioxidants: this equilibrium is essential for the survival of organisms and their health

Advertisement

7. Antioxidants in Cancer Assays

Humans have evolved with antioxidant systems for protection against free radicals and ROS. These systems include some antioxidants produced in the body (endogenous) and others obtained from the diet (exogenous) [21]. The former include

  1. enzymatic defenses, such as Se-glutathione peroxidase, catalase, and superoxide dismutase, which metabolize superoxide, hydrogen peroxide, and lipid peroxides, thus preventing the majority of the formation of toxic HO∙, and

  2. non-enzymatic defenses, such as glutathione, histidine peptides, the iron-binding transfer proteins and ferritin, and dihydrolipoic acid, reduced Coenzyme Q10, melatonin, urate, and plasma protein thiols, with the latter two accounting for the major contribution to the radical-trapping capacity of plasma.

The various defenses are complementary to each other because they act against different species in different cellular compartments. However, despite these defense antioxidants (able either to suppress free radical formation and chain initiation or to scavenge free radicals and chain propagation), some ROS escape to cause damage. Thus, the body’s antioxidant system is also provided with repair antioxidants (able to repair damage) and based on proteases, lipases, transferases, and DNA repair enzymes [145, 103].

Owing to the incomplete efficiency of our endogenous defense systems and the existence of some physiopathological situations (cigarette smoke, air pollutants, UV radiation, a high, polyunsaturated fatty acid diet, inflammation, ischemia/reperfusion, etc.) in which ROS are produced in excess and at the wrong time and place, dietary antioxidants are required to diminish the cumulative effects of oxidative damage throughout the human lifespan [149, 47). Well known natural antioxidants derived from the diet, such as vitamins C, E, and A and the carotenoids, have been studied intensively [124]. In addition to these, antioxidants in plants might account for at least part of the health benefits associated with vegetable and fruit consumption [103].

The plants, vegetables, and spices used in folk and traditional medicine have gained wide acceptance as one of the main sources of prophylactic and chemopreventive drug discovery and development [85, 29].

Some reports indicate that the prevalence of use of complementary and alternative medicine by patients with cancer has been estimated at a range of 7‒64% [3, 4, 58]. At present, many patients with cancer combine some forms of complementary and alternative therapy with their conventional therapies [4, 58]. A recent survey of patients at a comprehensive cancer center placed the use of vitamin and minerals at 62.6%; of these patients, 76.6% combined the use of vitamins and minerals with conventional chemotherapy [58, 27].

These types of patients employ complementary and alternative therapies for a variety of reasons [31, 14]: to improve quality of life (77%); to improve immune function (71%); to prolong life (62%), or to relieve symptoms (44%) related with their disease [31]. Only 37.5% of the patients surveyed expected complementary and alternative therapies to cure their disease. Whatever the reasons, alternative therapy use is on the rise and this includes the use of megavitamins, minerals, and cocktails of natural substances during chemotherapy administration; these cocktails include antioxidants such as the commonly consumed antioxidants vitamin E (mixed tocopherols and tocotrienols), vitamin C, β-carotene (natural mixed carotenoids), polyphenols, tannins, terpenoids, alkaloids, flavonoids, vitamin A, and many others. Controversy exists concerning the use of antioxidants with chemotherapy, but increasing evidence suggests a benefit when antioxidants are added to chemotherapy [111, 112, 106, 151, 117, 105, 22, 27].

It is widely accepted that diets rich in fruits and plants are rich sources of different types of antioxidants; phenolic compounds are the most studied of these and have been recognized to possess a wide range of properties including antioxidant, antibacterial, anti-inflammatory, hepatoprotective, and anticarcinogenic actions [3, 4, 63]. Many of the biological functions of flavonoid, phenolic, catechin, curcumin, resveratrol, and genistein compounds have been attributed to their free-radical scavenging, metal-ion chelating, and antioxidant activities [118, 152]. Antioxidant phenolic agents have been implicated in the mechanisms of chemoprevention, which refers to the use of chemical substances of natural or of synthetic origin to reverse, retard, or delay the multistage carcinogenic process [29].

It has been shown that dietary phytochemicals can interfere with each stage of the development of carcinogenesis [130, 93]. As in the case of direct antioxidant effects, dietary polyphenols are most likely to exert their chemopreventive effects on the gastrointestinal tract, where they are present at highest concentrations [52, 49, 84, 75]. Indeed, studies have shown that various polyphenol-rich fruits and vegetables are particularly effective in protecting against several types of cancer development [84, 75, 59]. Dietary polyphenols may exert their anticancer effects through several possible mechanisms, such as removal of carcinogenic agents, modulation of cancer cell signaling and antioxidant enzymatic activities, and induction of apoptosis as well as of cell cycle arrest. Some of these effects may be related, at least partly, with their antioxidant activities [59]. They may exert protective effects against cancer development, particularly in the gastrointestinal tract, where they will be at their highest concentration. In fact, many studies have shown that various polyphenol-rich fruits and vegetables are particularly effective in protecting against colon cancer development [84, 75].

At the cellular level, there is good evidence that polyphenols present in tea, red wine, cocoa, fruit juices, and olive oil; at some level, they are able to stimulate carcinogenesis and tumor development [93]. For example, they may interact with reactive intermediates [28] and activated carcinogens and mutagens [18], they may modulate the activity of the key proteins involved in controlling cell cycle progression [104], and they may influence the expression of many cancer-associated genes [142]. Perhaps most notably, the anticancer properties of green tea flavanols have been reported in animal models and in human cell lines (Takada et al., 2002], as well as in human intervention studies [60]. On the other hand, green tea consumption has been proposed as significantly reducing the risk of cancer of the biliary tract [133], bladder [110], breast [74], and colon [72]. Many of the anti-cancer properties associated with green tea are thought to be mediated by the flavanol Epigallocatechin gallate (EGCG), which has been shown to induce apoptosis and inhibit cancer cell growth by altering the expression of cell cycle regulatory proteins and the activity of signaling proteins involved in cell proliferation, transformation, and metastasis [66]. In addition to flavonoids, phenolic alcohols, lignans, and secoiridoids (all found at high concentrations in olive oil) are also thought to induce anti-carcinogenic effects [99] and have been reported in large intestinal cancer cell models [79], in animals [10, 128], and in humans [99]. These effects may be mediated by the ability of olive oil phenolics to inhibit initiation, promotion, and metastasis in human colon adenocarcinoma cells [42, 55] and to down-regulate the expression of COX-2 and Bcl-2 proteins, which play a crucial role in colorectal carcinogenesis [79, 146].

In vivostudies have demonstrated that many natural compounds found in plants and fruits have the capability to inhibit many types of human and animal cancer. Vitamins such as C, E, and A have shown that they can diminish cervical, bladder, prostate, intestinal, skin, and other gastrointestinal cancer types and that they have the capability to inhibit ROS production in patients [36, 37, 89, 134, 131, 62, 127]. In addition, it was demonstrated that these vitamins can inhibit progression and pathogenesis in colorectal cancer [12]. In animal models, vitamins showed promise for chemopreventive agents against several types of gastrointestinal cancer [62].

With the use of a combination of vitamins, selenium, β-carotene, essential fatty acids, and coenzyme Q10 in patients with breast cancer, it was observed that during the study no patient died, no patient showed signs of further distant metastasis, quality of life improved, and six patients showed apparent partial remission [80]. Human studies demonstrated that consumption of total antioxidants in the diet (fruits and vegetables) is inversely associated with the risk of distal gastric cancer [87]. Antioxidants, especially polyphenols, have been found to be promising agents against cervical cancer, including induction of apoptosis, growth arrest, inhibition of DNA synthesis, and modulation of signal transduction pathway; additionally, polyphenols can interfere with each stage of carcinogenesis initiation, promotion, and progression for the prevention of cancer development [26].

Camelia sinensistea, which contains a great quantity of polyphenols (epichatechin, (‒)‒epigallocatechin-3-gallate) is the most widely consumed beverage worldwide, and it was demonstrated that consumption of this beverage has shown to afford protection against chemical carcinogen-induced stomach, lung, esophagus, duodenum, pancreas, liver, breast, and colon carcinogenesis in specific bioassay models. The properties of the tea’s polyphenols make them effective chemopreventive agents against the initiation, promotion, and progression stages of multistage carcinogenesis [64]. Rosmanic acid had demonstrated to possess potent anticancer and apoptotic effect in mouse-induced skin cancer [121], curcumin, (‒)‒epigallocatechin-3-gallate, and lovastatin in combination were able to suppress esophageal cancer in mouse [154], and melatonin demonstrated diminishing the development and mortality of mouse implanted with murine hepatoma cells MN22a [39]. It was demonstrated that beta-ionone, a precursor of carotenoids, ameliorated lung carcinogenesis; the latter is attributed to the antiproliferative and antioxidant potential of beta-ionone through free radical scavenging properties [9]. Α-tocopherol showed down-regulation of the expression of the stress-activated genes PKC-α, c-Myc, and Lactate dehydrogenase A(LDHA)in cancerous mice, decreasing cancer cell proliferation [120]. It has been suggested that rosmanic acid suppresses oral carcinogenesis by stimulating the activities of detoxification enzymes, improving the status of lipid peroxidation and antioxidants, and down-regulating the expression of p53and bcl-2during 7,12 dimethylbenz(a)anthracene-induced oral carcinogenesis in hamster [8]. In the same manner, the methanolic extract of fennel seed exhibited an antitumoral affect by modulating lipid peroxidation and augmenting the antioxidant defense system in Ehrlich ascites carcinoma- bearing mice with or without exposure to radiation [94]. Silymarin, a natural flavonoid from the milk thistle seed, displayed chemopreventive action against 1,2-dimethylhydrazine plus dextran sodium sulfate-induced inflammation associated with colon carcinogenesis [135]. Quercetin, a flavonoid found in many natural foods, demonstrated to exert a direct oro-apoptotic affect on tumor cells and can indeed block the growth of several human cancer-cell lines in different cell-cycle phases, which have been demonstrated in several animal models [41]. The methanolic extract of Indigofera cassioideswas evaluated in terms of their antitumor activity on Ehrlich ascites carcinoma- bearing mice; the extract showed a potent antitumoral effect against tumor cells due its preventing lipid peroxidation and promoting the enzymatic antioxidant defense system in animals [69]. Brucine, a natural plant alkaloid, was reported to possess cytotoxic and antiproliferative activities and also had showed to be a potential anti-metastatic and -angiogenic agent [2].

An in vitroassay demonstrated that the mechanism’s antioxidant action, according to Halliwell [52], can include the following:

  1. suppressing ROS formation either by inhibiting the enzymes or chelating the trace elements involved in free radical production;

  2. scavenging ROS, and

  3. up-regulating or protecting antioxidant defenses.

Flavonoids have been identified as fulfilling the majority of the criteria previously described. Thus, their effects are two-fold as follows:

  1. Flavonoids inhibit the enzymes responsible for superoxide anion production, such as xanthine oxidase [54] and Protein kinase C (PKC) [140], and

  2. Flavonoids have also shown to inhibit cyclo-oxygenase, lipoxygenase, microsomal mono-oxygenase, glutathione S-transferase, mitochondrial succinoxidase, and (Nicoti-namide adenine denucleotide (NADH) oxidase, all of which are involved in ROS generation [68, 15].

A number of flavonoids efficiently chelate trace metals, which play an important role in oxygen metabolism. Free iron and copper are potential enhancers of ROS formation, as exemplified by the reduction of hydrogen peroxide with the generation of the highly aggressive hydroxyl radical [103].

On the other hand,invitro studies showed that the compounds present in fruits and vegetables, such as resveratrol, genestein, baicalein, and many others are attractive candidates for improved chemotherapeutic agents [35]. Resveratrol in combination with platinum drugs and oxaliplatin demonstrated that resveratrol administered 2 h prior to platinum drugs may sensitize ovarian cancer cells to platinum, inducing apoptosis and providing a means of overcoming resistance [95].

Ren [109] demonstrated that (‒)‒epigallocatechin-3-gallate induces reduction in IM9 myeloma cells and that its activity was dose- and time-dependent on the induction of apoptotic cell death; additionally, this natural metabolite combined with curcumin and lovastatin possessed the ability to suppress esophageal cancer-cell growth [154]. In multilla berries, it was found that their high levels of polyphenols, flavonoids, and flavonols and their antioxidants have a strong ability to reduce the viability of colon-cancer HT-29 and SW480 cell lines [33]. The anticancer activity of baicalein, a flavonoid found in several plants, was evaluated in a cutaneous squamous carcinoma-cell line, A431; it was found that this compound reduced the migration and invasiveness of the cells through inhibition of ezrin expression, which leads to the suppression of tumor metastasis [153].

In beans, it was found that these contain several compounds with cytotoxic activity on animals and human cell lines ( C33-A, SW480, and 3T3), which can be attributed to the antioxidants and damage to DNA caused by tannins, saponins, lectins, and others compounds found in the seed [143, 144].

Melastoma malabathricumshowed to have the ability to inhibit the proliferation of Caov-3, HL-60, CEM-SS, MCF-7, HeLa, and MDA-MB-231 cell lines, indicating that the leaves of this plant possess potential antiproliferative and antioxidant activities that could be attributed to its high content of phenolic compounds [122]. Melatonin, a naturally occurring compound, showed cytotoxic activity toward transformed 3T3-SV40 fibroblasts [143] and murine hepatoma cells MN22a, and it was shown that the sensitivities of both cell types to lysis by killer cells fell sharply [139].T he potent antioxidant activity of Kalanchoe gracilis (L.) DC stems due to that the polyphenolic compound found in this medicinal plant showed to have the ability to inhibit HepG2 cell proliferation [171], and the flavonoids found in Rosa caninaL. are responsible for the antiproliferative activity in HeLa, MCF7, and HT-29 cancer-cell lines [138]. Analysis of the fruit of Phelaria macrocarpa(Boerl.) Scheff and of Olea europaeaL. indicated that all parts of the fruit possess cytotoxic activity against HT-29, MCF-7, HeLa, BPH-1, and Chang cells, indicating that these fruits are a sources of bioactive compounds that are as potent as antioxidants and antioxidant agents, suggesting its possible use as an adjuvant agent in the treatment of cancer [56, 1].

The extract of Calluna vulgarisexhibited a photoprotective effect on human keratinocytes (HaCaT) exposed to Ultraviolet B (UVB) radiation [100]. Cachrys pungens Janwas analyzed in a human tumor- cell line, amelanotic melanoma, and it was found that its extract contains antioxidants, such as coumarins, which are responsible for their cytotoxicity in A375 cells [92]. Inonotus obliquusand Peperomia pellucida, plants employed as folk remedies for cancer treatment, were evaluated in several tumor cell-line types and it was found that these plants contains several antioxidants, such as lanosterol, inotodiols, ergosterol, phytol, 2-naphthalenol, decahydro hexadecanoic acid, methyl ester, and 9,12 octadecadienoic acid, indicating that these antioxidant compounds are responsible for the anticarcinogenic activity of the plant extract [129, 150]. The extract of Indigofera cassioidesindicated the presence antioxidant activity, preventing lipid peroxidation and promoting the enzymatic antioxidant defense system, and also showed potent antitumoral and cytotoxic affect against EAC, DLA, HeLa, Hep-2, HepG-2, MCF-7, Ht-29, and NIH 3T3 cells [69].

Hesperetin, hesperetin analog, carnocine, and resveratrol were evaluated for their antioxidant and anticarcinogenic activity on HT-29, HCT116, and mouse skin carcinogenesis; their studies demonstrated that these compounds can inhibit cell proliferation, induce apoptosis, affect glycolysis, and decrease tumoration [125, 161, 40]. Honey, a natural product commonly used throughout the world, contains antioxidant properties and exerts a preventive effect against disease. Chrysin is a natural flavone commonly found in honey, and it was demonstrated that this compound induced apoptosis in PC-3 cells [116], fennel seeds (Foeniculum vulgare) are present in antioxidants that have an anticancer potential against HepG2 and MCF-7 cell lines [94). It was indicated that compounds such as quercetin, flavonoids, and brucine have chemopreventive action against the osteosarcoma cell line (MG63), C6 glioma cells, and Ehrlich ascites cells, and that they can be used as anticancer, antigenotoxic agents and can induce apoptosis [135, 119, 2].

Advertisement

8. Conclusion

Oxidative stress causes injury to cells, induces gene mutation, and is involved in carcinogenesis and other degenerative diseases by directly or indirectly influencing intracellular signal transduction and transcription factors. The state of OS under carcinogenesis and tumor-bearing conditions is an intricate one in which various substances are involved in complex interactions.

The data discussed in this paper show that the biological effects of antioxidants on humans and animals can be controversial. Due to that the action of antioxidants depends on the oxidative status of cells, antioxidants can be protective against cancer; because ROS induce oxidative carcinogenic damage in DNA, antioxidants can prevent cancer in healthy persons harboring increased ROS levels.

Oxidative stress as cause and effect is not the sole factor in the development of cancer. It is important to take into account that there are other factors involved in its development, such as genetic predisposition, eating habits, environment, etc. Because ROS at moderate concentrations act as indispensable mediators of cancer-protective apoptosis and phagocytosis, an excess of antioxidants in persons with low ROS levels can block these cancer-preventive mechanisms. High doses of antioxidants can reduce the ROS level in persons who overproduce ROS and protect them against cancer and other ROS-dependent morbid conditions.

For individuals with low ROS levels, high doses of antioxidants can be deleterious, suppressing the already low rate of ROS generation and ROS-dependent cancer-preventive apoptosis. Screening and monitoring the human population regarding their ROS level can transform antioxidants into safe and powerful disease-preventive tools that could significantly contribute to the nation’s health.

Many in vivoand in vitrostudies performed to evaluate the capability of antioxidants against cancer, such as chemopreventive or therapeutic agents, were conduced employing natural antioxidants from fruits and vegetables; these are mainly supplied through food, which often do not provide sufficient input for these to function as chemoprotectors. Thus, humans are forced to consume antioxidants in a more direct manner, either in the form of a tablet, a pill, or any other form in order to supply the levels that the body requires of these compounds to protect it against cell damage caused by oxidation reactions, thus reducing the risk of certain cancer types, especially those of the epithelial surface and in the upper part of the body, such as breast, lung, kidney, liver, intestine, and many others that have been well documented. However, further investigations are expected before our better understanding of the function of many antioxidants and their utilization in the prevention and treatment of cancer and other degenerative diseases.

References

  1. 1. AcquavivaRDi GiacomoCSorrentiVGalvanoFSantangeloRCardileVGangiaSD’OrazioNAbrahamNGVanellaL2012International Journal of OncologyAntiproliferative effect of oleuropein in prostate cell linesPrint1791-2423Online1019-6439413138
  2. 2. AgrawalS. S.SaraswatiS.MathurR.PandeyM.2011Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell lineLife Science891471580024-3205
  3. 3. AkahP. A.EkekweR. K.1995Ethnopharmacology of some of the asteraceae family used in the Nigerian tradition al medicine.Fitoterapia663523550036-7326 X
  4. 4. AkinpeluD. A.1999Antimicrobial activity of Vernonia amygdalina leavesFitoterapia702322340036-7326 X
  5. 5. AllenR. G.TresiniM.2000Oxidative stress and gene regulation.Free Radical Biology & Medicine284634990891-5849
  6. 6. AndoK.FujitaT.2009Metabolic Syndrome and Oxidative StressFree Radical Biology & Medicine472132180891-5849
  7. 7. AndreazzaACKapczinskiFKauer-Sant’AnnaMWalzJCBondDJGonçalvesCAYoungLTYathamLN20093-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorderJournal of Psychiatry and Neuroscience1488-24344263271
  8. 8. AnusuyaCManoharanS2011Journal of Environmental Pathology, Toxicology and OncologyAntitumor initiating potential of rosmarinic acid in 7,12-dimethylbenz(a)anthracene-induced hamster buccal pouch carcinogenesisPrint0731-8898Online2162-653730199211
  9. 9. AsokkumarS.NaveenkumarC.RaghunandhakumarS.KamarajS.AnandakumarP.JaganS.DevakiT.2012Antiproliferative and antioxidant potential of beta-ionone against benzo(a)pyrene-induced lung carcinogenesis in Swiss albino miceMolecular and Cellular Biochemistry3633353450300-8177Print1573-4919(Online)
  10. 10. BartoliR.Fernandez-BanaresF.NavarroE.CastellaE.ManeJ.AlvarezM.PastorC.CabreE.GassullM.A.2000Effect of olive oil on early and late events of colon carcinogenesis in rats: Modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesisGut461911990017-5749Print1468-3288(Online)
  11. 11. BerlettBSStadtmanE. R.1997Protein Oxidation in Aging, Disease, and Oxidative StressThe Journal Of Biological Chemistry2723320313203160021-9258Print1083-351X(Online)
  12. 12. BhagatS. S.GhoneR. A.SuryakarA. N.HundekarP. S.2011Lipid peroxidation and antioxidant vitamin status in colorectal cancer patientsIndian Journal Physiology and Pharmacology5572760019-5499
  13. 13. BohrV.AnsonS.MazurR. M.DianovG.1998Oxidative DNA damage processing and changes with agingToxicology Letters Vols102-10347520378-4274
  14. 14. BoonH.StewartM.KennardMAGrayR.SawkaC.BrownJ. B.Mc WilliamC.GarvinA.BaronR. A.AaronD.Haines-KamkaT.2000Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptionsJournal of Clinical Oncology8251525210073-2183 X
  15. 15. BrownJ. E.KhodrH.HiderR. C.Rice-EvansC.1998Structural dependence of flavonoid interactions with Cu2+ ions: implications for their antioxidant properties.Biochemical Journal330117311780264-6021Print1470-8728(Online)
  16. 16. BrownN. S.BicknellR.2001Hypoxia and oxidative stress in breast cancer: Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancerBreast Cancer Research33233270167-6806Print1573-7217(Online)
  17. 17. CadetJ.DoukiT.RavanatJ. L.1997Artifacts associated with the measurement of oxidized DNA bases.Environmental Health Perspectives105103410390091-6765
  18. 18. CalommeM.PietersL.VlietinckA.VandenBerghe. D.1996Inhibition of bacterial mutagenesis by Citrus flavonoids.Planta Medica622222260032-0943
  19. 19. CarlsenM. H.HalvorsenB. L.HolteK.BøhnS. K.DraglandS.SampsonL.WilleyC.SenooH.UmezonoY.SanadaC.BarikmoI.BerheN.WillettW. C.PhillipsK.JacobsD. R. JrBlomhoffR.2010The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwideNutrition Journal93http://www.nutritionj.com/content/9/1/31475-2891
  20. 20. CejasP.CasadoE.Belda-IniestaC.De CastroJ.EspinosaE.RedondoA.SerenoM.García-CabezasM. A.VaraJ. A.Domínguez-CáceresA.PeronaR.González-BarónM.2004Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain)Cancer Causes and Control157077190957-5243Print1573-7225(Online)
  21. 21. ChenLHuJYWangSQ2012The role of antioxidants in photoprotection: A critical reviewJournal of the American Academy of Dermatology10.1016/j.jaad.2012.02.009[Epub ahead of print]0190-962201909622
  22. 22. ChineryR.BrockmanJ. A.PeelerM. O.ShyrY.BeauchampR. D.CoffeyR. J.1997Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPNature Medicine3123312411078-8956
  23. 23. Dal-PizzolF.RitterC.Cassol JrOj.RezinG. T.PetronilhoF.ZugnoA. I.QuevedoJ.StreckE. L.2009Oxidative Mechanisms of Brain Dysfunction During SepsisNeurochemical Research35112DOI: s11064-009-0043-40364-3190Print1573-6903(Online)
  24. 24. DelgadoO. L.BetanzosC. G.SumayaM. M. T.2010Importancia de los antioxidantes dietarios en la disminución del estrés oxidativoInvestigación y Ciencia5010151665-4412
  25. 25. De MejiaE. G.Valadez-VegaM. C.Reynoso-CamachoR.Loarca-PinaG.2005Tannins, trypsin inhibitors and lectin cytotoxicity in tepary (Phaseolus acutifolius) and common (Phaseolus vulgaris) beansPlant Foods Hum Nutr601371450921-9668
  26. 26. Di DomenicoFFoppoliCocciaCRPerluigiM2012Antioxidants in cervical cancer: Chemopreventive and chemotherapeutic effects of polyphenolsBiochimica et Biophysica Acta0005-27361822737747
  27. 27. DriskoJ. A.ChapmanJ.HunterV. J.2003The use of antioxidants with first-line chemotherapy in two cases of ovarian cancerJournal of the American College of Nutrition221181231665-4412
  28. 28. DuthieS. J.DobsonV. L.1999Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitroEuropean Journal of Nutrition3828340022-3166Print1541-6100(Online)
  29. 29. EbenezerO.FarombiA.Olatunde2011Antioxidative and chemopreventive properties of Vernonia amygdalina and Garcinia biflavonoidInternational Juornal of Environment Researc and Public Health8253325551661-7827Print1660-4601(Online)
  30. 30. EchartM. A. M.BarrioL. J. P.MariaGabriela.ValleG. M. G.AugustinS. C. H.Ugalde Marques da RochaMIManica-CattaniMFFeyl dos SantosGManica da CruzIB2009Association between manganese superoxide dismutase (MnSOD). gene polymorphism and elderly obesityMolecular and Cellular Biochemistry32833400300-8177Print1573-4919(Online)
  31. 31. ErnstE.CassilethB. R.1998The prevalence of complementary/alternative medicine in cancer: a systematic review.Cancer837777820000-8543 X(Print)1097-0142(Online)
  32. 32. EsterbauerH.SchauurJ. S.ZollnerH.1991Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydesFree Radical Biology & Medicine11811280891-5849
  33. 33. FlisS.JastrzebskiZ.NamiesnikJ.Arancibia-AvilaP.ToledoF.LeontowiczH.LeontowiczM.SuhajM.TrakhtenbergS.GorinsteinS.2012Evaluation of inhibition of cancer cell proliferation in vitro with different berries and correlation with their antioxidant levels by advanced analytical methodsJournal of Pharmaceutical Biomedical Analysis6268780731-7085
  34. 34. FloydR. A.WatsonJ. J.WongP. K.1986Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formationFree Radical Research Communications11631728755-0199
  35. 35. FoxJ. T.SakamuruS.HuangR.TenevaN.SimmonsS. O.XiaM.TiceR. R.CPAustinMyungK.2012High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell deathProceedings of the National Academy of Sciences of United States of America10954235428
  36. 36. Fuchs-TarlovskyV.Bejarano-RosalesM.Gutierrez-SalmeánG.CasillasMALópez-AlvarengaJ. C.Ceballos-ReyesG. M.2011Effect of antioxidant supplementation over oxidative stress and quality of life in cervical cancerNutrición Hospitalaria268198260212-1611
  37. 37. FukumuraHSatoMKezukaKSatoIFengXOkumuraSFujitaTYokoyamaUEguchiHIshikawaYSaitoT2012Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells.The Jornal of Physiological Sciences1880-6546(Print)1880-6562Online62251257
  38. 38. Gago-DominguezM.JiangX.CastelaoJ. E.2007Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesisBreast Cancer911110.1186/bcr1628http://breast-cancer-research.com/content/9/1/2010146-5542 X
  39. 39. GamaleĭI. A.KirpichnikovaK. M.FilatovaN. A.2011Effect of melatonin on the functional properties of transformed cellsVopr Onkol574814850507-3758
  40. 40. GeorgeJSinghMSrivastavaAKBhuiKRoyPChaturvediPKShuklaY2011Resveratrol and black tea polyphenol combination synergistically suppress mouse skin tumors growth by inhibition of activated MAPKs and p53PLoS One1932-620362339523408
  41. 41. GibelliniL.PintiM.NasiM.MontagnaJ. P.De BiasiS.RoatE.BertoncelliL.CooperE. L.CossarizzaA.2011Quercetin and cancer chemopreventionEvidence-Based Complementary and Alternative Medicine59135613650174-1427Print1741-4588(Online)
  42. 42. GillC. I.BoydA.Mc DermottE.Mc CannM.ServiliM.SelvagginiR.TaticchiA.EspostoS.MontedoroG.Mc GlynnH.RowlandI.2005Potential anti-cancer effects of virgin olive oil phenols on colorectal carcinogenesis models in vitro.International Journal of Cancer117170020-71361097-0215(Online)
  43. 43. GilleGSiglerK1995Folia MicrobiologicalOxidative stress and living cells0015-5632(Print)1874-9356(Online)40131152
  44. 44. GongG.WarisG.TanveerR.SiddiquiA.2001Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-BProceedings of the National Academy of Sciences of United States of America9817959996040027-8424
  45. 45. GrimsrudP. A.XieH.GriffinT. J.BernlohrD. A.2008Oxidative Stress and Covalent Modification of Protein with Bioactive AldehydesJournal of Biological Chemistry2833221837218410021-9258(Print)1083-351X(Online)
  46. 46. GuptaVSharmaM2012Phytochemical Analysis and Evaluation of Antioxidant Activities of Methanolic Extracts of Maytenus emarginata1536-2310(Print)1557-8100Online516257262
  47. 47. HalliwellB.1994Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?The Lancet3447217241040-6736
  48. 48. HalliwellB.1996Antioxidants in Human Health and Disease.Annual Reviews,1633501550-8382Online
  49. 49. HalliwellB.2000The antioxidant paradox.The Lancet1117911801040-6736
  50. 50. HalliwellB.GutteridgeJ. M. C.2006Free Radicals in Biology and MedicineEd 4. Clarendon Press, Oxford
  51. 51. HalliwellB.2007Oxidative stress and cancer: have we moved forward?Biochemical Journal4011110264-6021Print1470-8728(Online)
  52. 52. HalliwellB.2008Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies?Archives of Biochemistry and Biophysics4761071120003-9861Print1096-0384(Online)
  53. 53. HanR.M.TianY.X.BeckerE.M.AndersenM.L.ZhangJ.P.SkibstedL.H.2007Journal of Agricultural and Food ChemistryPuerarin and conjugate bases as radical scavengers and antioxidants: molecular mechanism and synergism with beta-carotene0021-8561Print1520-5118Online5523842389
  54. 54. HanasakiY.OgawaS.FukuiS.1994The correlation between active oxygens scavenging and antioxidative effects of flavonoidsFree Radical Biology & Medicine168458500891-5849
  55. 55. HashimY. Z.RowlandI. R.Mc GlynnH.ServiliM.SelvagginiR.TaticchiA.EspostoS.MontedoroG.KaisaloL.WahalaK.GillC. I.2008Inhibitory effects of olive oil phenolics on invasion in human colon adenocarcinoma cells in vitroInternational Journal of Cancer1224955000020-7136Print10970215Online
  56. 56. HendraR.AhmadS.OskoueianE.SukariA.ShukorM. Y.2011Antioxidant, anti-inflammatory and cytotoxicity of Phaleria macrocarpa (Boerl.) Scheff FruitBMC Complemententary & Alternative Medicine111101211472-6882
  57. 57. HippeliS.HeiserI.ElstnerE. F.1999Activated oxygen and free oxygen radicals in pathology: New insights and analogies between animals and plantsPlant Physiology Biochemistry371671780981-9428
  58. 58. HladikC.KriefS.HaxaireC.2005Ethnomedicinal and bioactive properties of plants ingested by wild chimpanzees in UgandaJournal Ethnopharmacology101150378-8741
  59. 59. HuM.L.2011Chang Gung Medical JournaDietary Polyphenols as Antioxidants and Anticancer Agents: More Questions than Answers2072-093934449459
  60. 60. InoueM.TajimaK.MizutaniM.IwataH.IwaseT.MiuraS.HiroseK.HamajimaN.TominagaS.2001Regular consumption of green tea and the risk of breast cancer recurrence: Follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan.Cancer Letters1671751820304-3835
  61. 61. IovineB.IannellaM. L.NocellaF.PricoloM. R.BevilacquaMA2012Carnosine inhibits KRAS-mediated HCT116 proliferation by affecting ATP and ROS productionCancer Letters281221280304-3835
  62. 62. JayaprakashV.MarshallJ. R.2011Selenium and other antioxidants for chemoprevention of gastrointestinal cancersBest Practtice & Research Clinical Gastroenterology255075181521-6918
  63. 63. JisakaM.OhigashiH.TakegawaK.HirotaM.IrieR.HuffmanMAKoshimizuK.1993Steroid glucosides from Vernonia amygdalina, a possible chimpanzee plant.Phytochemistry344094130031-9422
  64. 64. KatiyarS. K.MukhtarH.1997Tea antioxidants in cancer chemopreventionJournal of Cellular Biochemistry2759671097-4644
  65. 65. KellerJ.N.2006Interplay Between Oxidative Damage, Protein Synthesis, and Protein Degradation in Alzheimer’s DiseaseJournal of Biomedicine and Biotechnologyhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC1510934/pdf/JBB2006-12129.pdf1110-7243Print1110-7251Online200613
  66. 66. KhanN.AfaqF.SaleemM.AhmadN.MukhtarH.2006Targeting multiple signaling pathways by green tea polyphenol (−)-epigallocatechin-3-gallateCancer Research66250025050008-5472Print1538-7445Online
  67. 67. KleinschnitzC.GrundH.WinglerK.ArmitageMEJonesJ.MittalM.BaritD.SchwarzT.GeisC.KraftP.BarthelK.SchuhmannM. K.HerrmannA. M.MeuthS. G.StollG.MeurerS.SchreweA.BeckerL.Gailus-DurnerV.FuchsH.KlopstockT.Hrabe´ de AngelisM.Jandeleit-DahmK.ShahA. M.WeissmannN.SchmidtH. H. H. W.2010Post-Stroke Inhibition of Induced NADPH Oxidase Type 4Prevents Oxidative Stress and NeurodegenerationPloS Biology89http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.10004791545-78851544-9173
  68. 68. KorkinaL. G.Afanas’evI. B.1997Antioxidants in Disease Mechanisms and TherapySies, H., Ed.; Academic Press: San Diego151163
  69. 69. KumarRSRajkapoorBPerumalP2011Ex. DC. Asian Pacific Journal of Tropical MedicineIn vitro and in vivo anticancer activity of Indigofera cassioides Rottl1995-76454379385
  70. 70. La VecchiaC.AltieriA.TavaniA.2001Vegetables, fruit, antioxidants and cancer: a review of Italian studiesEuropean Journal of Nutrition402612671436-6207Print1436-6215Online
  71. 71. LaiZ. R.HoY. L.HuangS. C.HuangT. H.LaiS. C.TsaiJ. C.WangC. Y.HuangG. J.ChangY. S.2011Antioxidant, anti-inflammatory and antiproliferative activities of Kalanchoe gracilis (L.) DC stem.The American Journal of Chinese Medicine39127512900019-2415 XPrint1793-6853Online
  72. 72. LarsenCADashwoodR. H.2009Suppression of Met activation in human colon cancer cells treated with (−)-epigallocatechin-3-gallate: Minor role of hydrogen peroxideBiochemical and Biophysical Research Communnications3895275300000-6291 X
  73. 73. LeeC. K.WeindruchR.ProllaT. A.2000Gene-expression profile of the ageing brain in miceNature Genetics252942971061-4036
  74. 74. LeongH.MathurP. S.GreeneG. L.2008Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green tea.Breast Cancer Research and Treatment1073593690167-6806Print0167-6806Print1573-7217Online
  75. 75. LiQ.ZhaoH. F.ZhangZ. F.LiuZ. G.PeiX. R.WangJ. B.CaiM. Y.LiY.2009Long-term administration of green tea catechins prevents age-related spatial learning and memory decline in C57BL/6 J mice by regulating hippocampal cyclic AMP-response element binding protein signaling cascadeNeuroscience159120812150306-4522
  76. 76. LiW.ShiY. H.YangR. L.CuiJ.XiaoY.WangB.LeG. W.2010Effect of somatostatin analog on high-fat diet-induced metabolic syndrome: Involvement of reactive oxygen speciesPeptides3146256290196-9781
  77. 77. LiangW.LiX.LiC.LiaoL.GaoB.GanH.YangZ.LiaoL.ChenX.2011Quercetin-mediated apoptosis via activation of the mitochondrial-dependent pathway in MG-63 osteosarcoma cellsMolecular Medicine Reports4101710231791-2997Print1791-3004Online
  78. 78. LiuM.GongX.AlluriR. K.WuJ.SabloT.LiZ.2012Characterization of RNA damage under oxidative stress in Escherichia coliBiol Chem39331231321437-4315
  79. 79. LlorX.PonsE.RocaA.AlvarezM.ManeJ.Fernandez-BanaresF.GassullM. A.2003The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processesClinical Nutrition2271790261-5614
  80. 80. LockwoodK.MoesgaardS.HaniokaT.FolkersK.1994Apparent partial remission of breast cancer in ‘High Risk’ patients supplemented with nutritional antioxidants, essential fatty acids and Coenzyme Q10Biochemical and Biophysical Research Communications15231s2400000-6291 X
  81. 81. MaQKinneerK.2002Chemoprotection by phenolic antioxidants. Inhibition of tumor necrosis factor alpha induction in macrophagesJournal of Biological Chemistry0021-9258Print1083-351XOnline27724772484
  82. 82. MaritimA. C.SandersR. A.WatkinsI. I. I. J. B.2003Diabetes, Oxidative Stress, and Antioxidants: A ReviewJournal of Biochememical Molecular and Toxicology1724381095-6670Print1099-0461Online
  83. 83. MarkesberyW. R.1997Oxidative Stress Hypothesis In Alzheimer’s DiseaseFree Radical Biology & Medicine2311341470891-5849
  84. 84. MartinezM. E.2005Primary prevention of colorectal cancer: Lifestyle, nutrition, exerciseRecent Results in Cancer Research1661772110080-0015
  85. 85. MatésJMSeguraJAAlonsoFJMárquezJ.2011Current Medicinal ChemistryAnticancer antioxidant regulatory functions of phytochemicals0929-8673Print1875-533XOnline1823152338
  86. 86. MatesJ. M.Perez-GomezC.Nunez de CastroI.1999Antioxidant enzymes and human diseases.Clinical Biochemistry325956030009-9120
  87. 87. MauroS.RinoB.AlicjaW.MEAnna(2002.2002Total antioxidant potential of fruit and vegetables and risk of gastric cancerGastroenterology1239859910016-5085
  88. 88. MaxmenA.2012The Hard FactsNature485S50S510028-0836
  89. 89. MazdakH.ZiaH.2012Vitamin e reduces superficial bladder cancer recurrence: a randomized controlled trialInternational Journal of Preventive Medicine3110115
  90. 90. McCordJ. M.FridovichI.1968The Journal of Bioogical ChemistryThe reduction of cytochrome c by milk xanthine oxidase2008-7802Print2008-8213Online24357535760
  91. 91. Medina-CejaL.Guerrero-CazaresH.Canales-AguirreA.Morales-VillagránA.Feria-VelascoA.2007Características estructurales y funcionales de los transportadores de glutamato: su relación con la epilepsia y el estrés oxidativoRevista de Neurología456341352
  92. 92. MenichiniGAlfanoCProvenzanoEMarrelliMStattiGAMenichiniFConfortiF2012Cachrys pungens Jan inhibits human melanoma cell proliferation through photo-induced cytotoxic activityCell Proliferation0960-7722Print1365-2184Online453947
  93. 93. MiddletonE. JrKandaswamiC.TheoharidesT. C.2000The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancerPharmacological Reviews526737510031-6997
  94. 94. MohamadR. H.El -BastawesyA. M.Abdel-MonemM. G.NoorA. M.Al-MehdarH. A.SharawyS. M.El -MerzabaniMM2011Antioxidant and anticarcinogenic effects of methanolic extract and volatile oil of fennel seeds (Foeniculum vulgare)Journal of Medicine Food,1498610010109-6620Print1557-7600Online
  95. 95. NessaM. U.BealeP.ChanC.YumJ. Q.HuqF.2012Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cellsAnticancer Res3253590250-7005Print1791-7530Online
  96. 96. NodaN.WakasugiH.2000Cancer and oxidative stressJournal of the Japan Medical Association12411157115741356-8650
  97. 97. NunomuraA.HondaK.TakedaA.HiraiK.ZhuX.SmithM. A.PerryG.2006Oxidative Damage to RNA in Neurodegenerative DiseasesJournal of Biomedicine and Biotechnology82323161110-7243Print1110-7251Online
  98. 98. NyströmN.2005Role of oxidative carbonylation in protein quality control and senescenceEMBO Journal0261-4189Print1460-2075Online2413111317
  99. 99. OwenR. W.GiacosaA.HullW. E.HaubnerR.SpiegelhalderB.BartschH.2000The antioxidant/anticancer potential of phenolic compounds isolated from olive oilEuropean Journal Cancer36123512470959-8049
  100. 100. Perde-SchreplerMCherechesGBrieLViragPBarbo,sOSoritauOTatomirCFischer-FodorEFilipAVlaseLPostescuID2011Photoprotective effect of Calluna vulgaris extract against UVB-induced phototoxicity in human immortalized keratinocytes.Journal of Environment Pathology Toxicology and Oncology0371-8898Print2162-6537Online30323331
  101. 101. PereraR. M.BardeesyN.2011When antioxidants are badNature440028-0836
  102. 102. PietáD.Martins DeLima. M. N.Presti-TorresJ.DornellesA.GarciaV. A.SicilianiS. F.RewsaatM. G.ConstantinoL.BudniP.Dal-PizzolF.SchröderaN.2007Memantine Reduces Oxidative Damage And Enhances Long-Term Recognition Memory In Aged RatsNeuroscience146171917250306-4522
  103. 103. PiettaP. G.2000Flavonoids as AntioxidantsJournal of Natural Produts103510420163-3864Print1520-6025Online
  104. 104. PlaumannB.FritscheM.RimplerH.BrandnerG.HessR. D.1996Flavonoids activate wild-type p53Oncogene13160516140950-9232
  105. 105. PrasadK. N.KumarmA.KochupillaimV.ColemW. C.1999High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapyJournal of the American College of Nutrition1813250731-5724Print1541-1087Online
  106. 106. PrasadK. N.ColeW. C.KumarB.PrasadK. C.2001Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapiesJournal of the American College of Nutrition20450S463S0731-5724Print1541-1087Online
  107. 107. PriceT. O.ErcalN.NakaokeR.BanksW. A.2005HIV-1viralproteins gp120 and Tatinduceoxidativestress in brain endothelial cellsBrain Research104557630006-8993
  108. 108. RabekJ. P.BoylstonI. I. I. W. H.PapaconstantinouJ.2003Carbonylation of ER chaperone proteins in aged mouse liverBiochemical and Biophysical Research Communications3055665720000-6291 X
  109. 109. RenL.YangH. Y.ChoiH. I.ChungK. J.YangU.LeeI. K.KimH. J.DSLeeParkB. J.LeeT. H.2011The role of peroxiredoxin V in (-)-epigallocatechin 3-gallate-induced multiple myeloma cell deathOncology Research193913980965-0407
  110. 110. Rieger-ChristKMHanleyRLodowskyCBernierTVemulapalliPRothMKimJYeeASLeSMMariePJLibertinoJASummerhayesIC2007The green tea compound, (−)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cellsJournal of Cellular Biochemistry0730-2312Print1097-4644Online102377388
  111. 111. RiordanN. H.RiordanH. D.MengY. L.JacksonJ. A.1995Intravenous ascorbate as a tumor cytotoxic. chemotherapeutic agentMedical Hypotheses442072130306-9877
  112. 112. RiordanN. H.RiordanH. D.CasciariJ. P.2000Clinical and experimental experiences with intravenous vitamin CJournal of Orthomolecular Medicine52012130317-0219
  113. 113. RivasMACarnevaleR. P.ProiettiC. J.RosemblitC.BeguelinW.SalatinoM.CharreauE. H.FrahmI.SapiaS.BrouckaertP.ElizaldeP. V.SchillaciR.2008TNF alpha acting on TNFR1 promotes breast cancer growth via P42 P44 MAPK, JNK, Akt and NF-kappa B-dependent pathwaysExperimental Cell Research3143509290014-4827
  114. 114. RobertsC. K.BarnardaR. J.SindhubR. K.JurczakM.EhdaiebA.VaziriN. D.2006Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndromeMetabolism Clinical and Experimental559289341532-8600
  115. 115. RocheCERomeroA. D.1994Estrés oxidativo y degradación. de proteínasMedicina clínica51031891960025-7753
  116. 116. SamarghandianSAfshariJTDavoodiS2011Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3Clinics (Sao Paulo)1807-5932Print1980-5322Online6610731079
  117. 117. SchmittCALoweS. W.1999Apoptosis and therapyThe Journal of Pathololy187127137
  118. 118. SeefL. B.LindsayK. L.BaconB. R.KresinaF.HoofnagleH.2001Complementary and alternative medicine in chronic liver diseaseHepatology345956031096-9896Online
  119. 119. SeibertHMaserESchwedaKSeibertSGüldenM2011Cytoprotective activity against peroxide-induced oxidative damage and cytotoxicity of flavonoids in C6 rat glioma cells.Food and Chemical Toxicology0278-69154923982407
  120. 120. SharmaR.VinayakM.2012Antioxidant α-tocopherol checks lymphoma promotion via regulation of expression of protein kinase C-α and c-Myc genes and glycolytic metabolism.Leukemia & Lymphoma1042-8194Print1029-2403Online65312031210
  121. 121. SharmilaR.ManoharanS.2012Anti-tumor activity of rosmarinic acid in 7,12-dimethylbenz(a) anthracene (DMBA) induced skin carcinogenesis in Swiss albino miceIndian Journal of Experimental Biology501871940975-1009Print0019-5189Online
  122. 122. ZakariaZ. A.RofieeMSMohamedA. M.theL. K.SallehM. Z.2011In vitro antiproliferative and antioxidant activities and total phenolic contents of the extracts of Melastoma malabathricum leavesJournal of Acupuncture and Meridian Studies442482560000-0020
  123. 123. SiesH.1997Antioxidants in Disease Mechanisms and TherapyAdvances in Pharmacology38Academic Press: San Diego
  124. 124. SiesH.1997Oxidative Stress: Oxidants And AntioxidantsExperimental Physiology822912950958-0670Print1469-445XOnline
  125. 125. SivagamiG.VinothkumarR.PreethyCPRiyasdeenA.AkbarshaMAMenonV. P.NaliniN.2012Role of hesperetin (a natural flavonoid) and its analogue on apoptosis in HT-29 human colon adenocarcinoma cell line- A comparative studyFood and Chemical Toxicology506606710278-6915
  126. 126. SkalickyJ.MuzakovaV.,.RomanKandar. R.MelounM.RousarT.PalickaV.2008Evaluation of oxidative stress and inflammation in obese adults with metabolic syndromeClinical Chemistry and Laboratory Medicine4644995051434-6621Print1437-4331Online
  127. 127. SlagaT. J.1995Inhibition of the induction of cancer by antioxidantsAdvances in Experimental Medicine and Biology3691671740065-2598
  128. 128. SolanasMHurtadoACostaIMoralRMenendezJ.A.ColomerR.EscrichE.2002International Journal of OncologyEffects of a high olive oil diet on the clinical behavior and histopathological features of rat DMBA-induced mammary tumors compared with a high corn oil diet1791-242321745753
  129. 129. SunYYinTChenXHZhangGCurtisRBLuZHJiangJH2011In vitro antitumor activity and structure characterization of ethanol extracts from wild and cultivated Chaga medicinal mushroom, Inonotus obliquus (Pers.:Fr.) Pilát (Aphyllophoromycetideae)International Journal of Medical Mushrooms1521-9437Print1940-4344Online13121130
  130. 130. SurhYJ.2003Cancer chemoprevention with dietary phytochemicalsNature Review Cancer37687801097-0142Online
  131. 131. SzpetnarM.MatrasP.Kiełczykowsk,aM.HoreckaA.BartoszewskaL.PasternakK.RudzkiS.2012Antioxidants in patients receiving total parenteral nutrition after gastrointestinal cancer surgeryCell Biochemistry and Funciont302112161099-0844Online
  132. 132. TakadaMKuY.HabaraKAjikiT.SuzukiY.KurodaY.2002Inhibitory effect of epigallocatechin-3-gallate on growth and invasion in human biliary tract carcinoma cellsWorld Journal of Surgery0364-2313Print1432-2323Online26683686
  133. 133. TakadaM.NakamuraY.KoizumiT.ToyamaH.KamigakiT.SuzukiY.TakeyamaY.KurodaY.2002Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallatePancreas2545480885-3177Print1536-4828Online
  134. 134. ThapaD.GhoshR.2012Antioxidants for prostate cancer chemoprevention: Challenges and opportunitiesBiochemical Pharmacology83131913300006-2952
  135. 135. Toyoda-HokaiwadoNYasuiYMuramatsuMMasumuraKTakamuneMYamadaMOhtaTTanakaTNohmiT.2011Chemopreventive effects of silymarin against 1,2-dimethylhydrazine plus dextran sodium sulfate-induced inflammation-associated carcinogenicity and genotoxicity in the colon of gpt delta ratsCarcinogenesis0143-3334Print1460-2180Online3215121517
  136. 136. ToyokuniMD1998Oxidative Stress and Cancer: The Role of Redox Regulation ShinyaBiotherapy111471540092-1299 XPrint1573-8280Online
  137. 137. TsaluchiduS.CocchiM.TonelloL.PuriB. K.2008Fatty acids and oxidative stress in psychiatric disordersBMC Psychiatry81S1S50147-1244 XOnline
  138. 138. TumbasV. T.Canadanović-BrunetJ. M.Cetojević-SiminD. D.CetkovićG. S.EthilasS. M.GilleL.2012Effect of rosehip (Rosa canina L.) phytochemicals on stable free radicals and human cancer cellsJournal of the Science of Food and Agriculture92127312810022-5142Print1097-0010Online
  139. 139. UphamB. L.WagnerJ. G.2001Toxicological Highlight Toxicant-Induced Oxidative Stress in CancerToxicological sciences64131096-6080Print1096-0929Online
  140. 140. UrsiniF.MaiorinoM.MorazzoniP.RoveriA.PifferiG.1994A novel antioxidant flavonoid (IdB 1031) affecting molecular mechanisms of cellular activationFree Radical Biology & Medicine165475530891-5849
  141. 141. UttaraB.SinghA. V.ZamboniP.MahajanR. T.2009Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic OptionsCurrent Neuropharmacology765740157-0159 X
  142. 142. Van ErkM. J.RoepmanP.van der LendeT. R.StierumR. H.AartsJ. M.van BladerenP. J.van OmmenB.2005Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitroEuropean Journal of Nutrition441431561436-6207Print1436-6215Online
  143. 143. Valadez-VegaC.Guzmán-PartidaA. M.Soto-CordovaF. J.Alvarez-ManillaG.Morales-GonzálezJ. A.Madrigal-SantillánE.Villagómez-IbarraJ. R.Zúñiga-PérezC.Gutiérrez-SalinasJ.Becerril-FloresMA2011Purification, biochemical characterization, and bioactive properties of a lectin purified from the seeds of white tepary bean (phaseolus acutifolius variety latifolius)Molecules21256125821420-3049
  144. 144. Valadez-VegaC.Alvarez-ManillaGRiverón-NegreteLGarcía-CarrancáAMorales-GonzálezJAZuñiga-PérezCMadrigal-SantillánEEsquivel-SotoJEsquivel-ChirinoCVillagómez-IbarraRBautistaMMorales-GonzálezA2011Detection of cytotoxic activity of lectin on human colon adenocarcinoma (Sw480) and epithelial cervical carcinoma (C33-A)Molecules1420-3049221072118
  145. 145. VarmaSDDevamanoharanS.MorrisSM1995Prevention of cataracts by nutritional and metabolic antioxidantsCrititical Reviews in Food Science and Nutrition351111291040-8398Print1549-7852Online
  146. 146. VauzourDRodriguez-MateosACoronaGOruna-ConchaMJSpenceJPE2010Polyphen ols and Human Health: Prevention of Disease and Mechanisms of ActionNutrients2072-6643211061131
  147. 147. WarburgO.1956On the origin of cancer cellsScience1233093140036-8075Print1095-9203Online
  148. 148. WarisG.SiddiquiA.2005Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replicationJournal of Virology799725340002-2538 XPrint1098-5514Online
  149. 149. WaynerD. D. M.BurtonG. W.IngoldK. U.BarclayL. R. C.LockeS. J.1987The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasmaBiochemica et Biophysica Acta9244084190006-3002
  150. 150. WeiL. S.WeeW.SiongJ. Y.SyamsumirD. F.2011Charactetization of anticancer, antimicrobial, antioxidant properties and chemical composition of Peperomia pellucidActa Medica Iranica496706740044-6025Print1735-9694Online
  151. 151. WeijlN. I.CletonF. J.OsantoS.1997Free radicals and antioxidants in chemotherapy induced toxicityCancer Treatment Reviews232092400305-7372Print
  152. 152. WinslowLCKrolDJ1998Herbs as medicinesArchives Internal Medicine0003-9926Print1538-3679Online12582192219
  153. 153. WuBLiJHuangDWangWChenYLiaoYTangXXieHTangF2011Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through Ezrin in A431 cells1471-240711527536
  154. 154. YeFZhangGHGuanBXXuXC2012World Journal of GastroenterologySuppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin1007-9327Print2219-2840Online18126135

Written By

Carmen Valadez-Vega, Luis Delgado-Olivares, José A. Morales González, Ernesto Alanís García, José Roberto Villagomez Ibarra, Esther Ramírez Moreno , Manuel Sánchez Gutiérrez, María Teresa Sumaya Martínez, Zuñiga Pérez Clara and Zuli Calderón Ramos

Submitted: March 30th, 2012 Reviewed: July 11th, 2012 Published: May 22nd, 2013